Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | SLC16A3 | O15427 | 7/20 | 0.48 |
| ▸ | PARP1 | P09874 | 1/20 | 0.44 |
| ▸ | ABL1 | P00519 | 1/20 | 0.43 |
| ▸ | SRC | P12931 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.42 |
| ▸ | CFTR | P13569 | 1/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3863550 | 0.85 | SMN1; SMN2 (0.57) | KMT2AMEN1TDP1SLC16A3 | |
| Methylamine SCHEMBL27546412 | 0.82 | SLC16A3 (0.53) | KMT2AMEN1TDP1SLC16A3PARP1 | |
| SCHEMBL14280280 | 0.82 | SLC16A3 (0.55) | KMT2AMEN1TDP1SLC16A3PARP1 | |
| SCHEMBL13645650 | 0.82 | SMN1; SMN2 (0.56) | KMT2AMEN1RXFP1 | |
| SCHEMBL13292708 | 0.82 | ALDH1A1 (0.44) | KMT2AMEN1SLC16A3MAPK1ESR2 | |
| SCHEMBL13645619 | 0.81 | MAPK1 (0.69) | KMT2AMEN1MAPK1ESR2 | |
| SCHEMBL13645568 | 0.81 | ATM (0.48) | KMT2ATDP1SLC16A3MAPK1ESR2 | |
| SCHEMBL12995254 | 0.81 | TDP1 (0.55) | KMT2AMEN1TDP1SLC16A3RXFP1 | |
| SCHEMBL4831437 | 0.80 | SLC16A3 (0.60) | KMT2AMEN1TDP1SLC16A3 | |
| SCHEMBL13645578 | 0.79 | ALDH1A1 (0.44) | KMT2AMEN1SLC16A3MAPK1RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7598389-B2 | Silylated carboxamides | BAYER CROPSCIENCE AG (DE) | 2009-10-06 | — | — | US | disclosed |
| US-20070191454-A1 | Silylated carboxamides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2007-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070191454-A1 | Silylated carboxamides | MRPL21, MRPS22, MRPS34 | KMT2A 707/4885MEN1 1995/4885TDP1 3851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.